GlassScriptPhysician profile
Roger A Abrahams
NPI 1407826787
$133,311.81
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $103K · 2020: $20K · 2021: $6,572 · 2022: $4,246.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $129,209.03 | 2019-2022 | |
| Astrazeneca Uk Limited | $1,682.94 | 2019 | |
| Boehringer Ingelheim International Gmbh | $1,207.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $723.75 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.87 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $54.42 | 2019 | |
| Mylan Specialty L.P. | $46.61 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $40.14 | 2019 | |
| Philips North America LLC | $34.81 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $33.42 | 2022 | |
| Advanced Respiratory, INC | $28.48 | 2020 | |
| Csl Behring | $15.60 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.90 | 2020 | |
| Genzyme Corporation | $14.79 | 2019 | |
| Genentech USA, INC. | $12.81 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$8,121.95 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Abrahams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.